What does Axsome Therapeutics, Inc. do?

Jun 22 2025 06:23 PM IST
share
Share Via
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. As of March 2025, it reported net sales of $121 million and a net loss of $59 million, with a market cap of approximately $5 billion.
Overview:
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain, and operates in the Pharmaceuticals & Biotechnology industry within the small-cap market.

Financial Snapshot:
Most recent Net Sales: 121 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -59 Million (Quarterly Results - Mar 2025)
Market-cap: USD 5,002.41 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -2.13
Return on Equity: -464.66%
Price to Book: 94.02

Contact Details:
Address: 22 CORTLANDT STREET, 16TH FLOOR, NEW YORK NY: 10007
Tel: 1 212 3323241
Fax: 1 212 3200245
Website: http://axsome.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Axsome Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:03 PM IST
share
Share Via
Is Axsome Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:38 AM IST
share
Share Via
How big is Axsome Therapeutics, Inc.?
Jun 22 2025 05:48 PM IST
share
Share Via